MSC-NP (autologous mesenchymal stem cell-derived neural progenitors)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MSC-NP (autologous mesenchymal stem cell-derived neural progenitors), covering 2018-03-19 to 2018-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis [Phase 1]